file - European Urology

advertisement
Supplementary Table 1. Studies contributing prevalence data (any UUI) to estimate
of unadjusted mean prevalence of UUI according to age interval and gender
Gender
Men
Study
Foley et al 2012
[1]
Wang et al 2011
[2]
Irwin et al 2006
[3]
Diokno et al
2007[4,5]
Fig. 1A
Fig. 1B
1829
3039
6069
≥70
-
-
-
-
-
24.1%
0%†
1%†
1%†
2%†
5%†
9.4%
0.8%
(1839 y)
3.2%†
(1834 y)
0.5%*
(1839 y)
1.5%*
(4059 y)
3.7%
(≥60 y)
18.2%†
(6574
y)
8.2%
(6574
y)
21.5%
(6574
y)
10.9*
(≥60 y)
0.8%
(1839 y)
1.7%
(4059 y)
3.7%
(≥60 y)
0.7%
(1839 y)
1.6%
(4059 y)
7.3%
(≥60 y)
Stewart et al
2003 [6]
1%†
(1834 y)
Corcos et al
2004 [7]
-
Mean
prevalence
collapsed (red
data)
Mean
prevalence
(green data)
Mean
prevalence (red
and green data)
Mean
prevalence (blue
data)
Women
de Ridder et al
2013 [8]
Foley et al 2012
[1]
Felde et al 2012
[9]
Wang et al 2011
[2]
Zhu et al 2010
[10]
Zhu et al 2008
[11]
Tegerstedt et al
2005 [12]
Hannestad et al
2000 [13]
Zhang et al 2005
Age, y
4049
5059
3.4%†
(3544
y)
2%†
(3544
y)
11.1%
(3544
y)
2.1%
(1834 y)
5.5%
(3544
y)
1.7%
(4059 y)
6.1%†
(4554 y)
10.5%†
(5564 y)
3%†
(4554 y)
3%†
(5564 y)
14.3%
(4554 y)
17.5%
(5564 y)
7.8%
(4554 y)
10.3%
(5564 y)
16.0%
(6574
y)
23.7%†
(≥75 y)
10.2%
(≥75 y)
29.5%
(≥75 y)
21.1%
(≥75 y)
1829
3039
4049
5059
6069
≥70
-
-
25.2%
34.7%
42.6%
51.9%*
-
-
-
-
-
25.4%
-
-
10.2%
-
-
-
0%†
0%†
1%†
3%†
6%†
15.1%
1.3%
2.3%
5.7%
4%†
7%†
12%†
19†
23%†
40%*†
-
33%†
46%†
59%†
63%†
73%†
21.8%*
18.3%*
17.8%*
22.3%*
29.0%*
31.1%*
6.9%†
7.4%†
8.0%†
17.0%†
26.0%†
37.6%†
[14]
Araki et al 2005
[15]
Melville et al
2005 [16]
Lee et al 2008
[17]
Ge et al 2011
[18]
Irwin et al 2006
[3]
Rohr et al 2005
[19]
Dooley et al
2008 [20]
Stewart et al
2003 [6]
Corcos et al
2004 [7]
Fig. 1A
Fig. 1B
Mean
prevalence (red
data) collapsed
Mean
prevalence
(green data)
Mean
prevalence (red
and green data)
Mean
prevalence (blue
data)
1.3%*†
7.5%*†
13.3%*†
16.3%*†
-
-
-
14.2%*
22.0%*
31.4%*
34.7%*
40.7%*
1.6%
-
3%†
(2039 y)
2.0%
(1839 y)
-
8%†
24.9%
(≥60 y)
12%†
13%†
11.4%*
(1839 y)
19.1%*
(4059 y)
6.6%
(≥60 y)
59.8%*
(≥60 y)
40.4%*
(≥60 y)
19.1%
(6574
y)
24.0%
(6574
y)
32.6%*
(≥60 y)
5.8%
(1839 y)
15.6%
(4059 y)
32.9%
(≥60 y)
8.6%
(1839 y)
17.4%
(4059 y)
32.8%
(≥60 y)
12.3%*
(1839 y)
2.5%†
(1834 y)
-
2.5%
(1834 y)
3.9%
(4059 y)
-
28%†
4%†
(3544
y)
17.9%
(3544
y)
11.0%
(3544
y)
27.3%*
(4059 y)
12%†
(4554 y)
12%†
(5564 y)
21.1%
(4554 y)
26.8%
(5564 y)
16.6%
(4554 y)
19.4%
(5564 y)
21.6%
(6574
y)
18.5†%
(≥75 y)
21.4%
(≥75 y)
20.0%
(≥75 y)
Includes studies that reported prevalence data according to age directly or in graphs from which
data were imputed. Data were collapsed from studies with 10-y age intervals to 20-y age
intervals, when possible (red data).
*Prevalence value imputed based on values from different age intervals.
†Prevalence value imputed from graphic data.
References
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
Foley, AL, Loharuka, S, Barrett, JA, Mathews, R, Williams, K, McGrother, CW, et al.
Association between the Geriatric Giants of urinary incontinence and falls in older people using
data from the Leicestershire MRC Incontinence Study. Age Ageing 2012;41(1):35-40.
Wang, Y, Xu, K, Hu, H, Zhang, X, Wang, X, Na, Y, et al. Prevalence, risk factors, and impact on
health related quality of life of overactive bladder in China. Neurourol Urodyn 2011;30(8):14481455.
Irwin, DE, Milsom, I, Hunskaar, S, Reilly, K, Kopp, Z, Herschorn, S, et al. Population-based
survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in
five countries: results of the EPIC study. Eur Urol 2006;50(6):1306-1314; discussion 1314-1305.
Diokno, AC, Estanol, MV, Ibrahim, IA, Balasubramaniam, M. Prevalence of urinary
incontinence in community dwelling men: a cross sectional nationwide epidemiological survey.
Int Urol Nephrol 2007;39(1):129-136.
Benner, JS, Becker, R, Fanning, K, Jumadilova, Z, Bavendam, T, Brubaker, L, et al. Bother
related to bladder control and health care seeking behavior in adults in the United States. J Urol
2009;181(6):2591-2598.
Stewart, WF, Van Rooyen, JB, Cundiff, GW, Abrams, P, Herzog, AR, Corey, R, et al. Prevalence
and burden of overactive bladder in the United States. World J Urol 2003;20(6):327-336.
Corcos, J, Schick, E. Prevalence of overactive bladder and incontinence in Canada. Can J Urol
2004;11(3):2278-2284.
de Ridder, D, Roumeguere, T, Kaufman, L. Overactive bladder symptoms, stress urinary
incontinence and associated bother in women aged 40 and above; a Belgian epidemiological
survey. Int J Clin Pract 2013;67(3):198-204.
Felde, G, Bjelland, I, Hunskaar, S. Anxiety and depression associated with incontinence in
middle-aged women: a large Norwegian cross-sectional study. Int Urogynecol J 2012;23(3):299306.
Zhu, L, Lang, J, Liu, C, Xu, T, Liu, X, Li, L, et al. Epidemiological study of urge urinary
incontinence and risk factors in China. Int Urogynecol J 2010;21(5):589-593.
Zhu, L, Lang, J, Wang, H, Han, S, Huang, J. The prevalence of and potential risk factors for
female urinary incontinence in Beijing, China. Menopause 2008;15(3):566-569.
Tegerstedt, G, Maehle-Schmidt, M, Nyren, O, Hammarstrom, M. Prevalence of symptomatic
pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct
2005;16(6):497-503.
Hannestad, YS, Rortveit, G, Sandvik, H, Hunskaar, S, Norwegian, EsEoIitCoN-T. A communitybased epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study.
Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol
2000;53(11):1150-1157.
Zhang, W, Song, Y, He, X, Xu, B, Huang, H, He, C, et al. Prevalence and risk factors of lower
urinary tract symptoms in Fuzhou Chinese women. Eur Urol 2005;48(2):309-313.
Araki, I, Beppu, M, Kajiwara, M, Mikami, Y, Zakoji, H, Fukasawa, M, et al. Prevalence and
impact on generic quality of life of urinary incontinence in Japanese working women: assessment
by ICI questionnaire and SF-36 Health Survey. Urology 2005;66(1):88-93.
Melville, JL, Katon, W, Delaney, K, Newton, K. Urinary incontinence in US women: a
population-based study. Arch Intern Med 2005;165(5):537-542.
Lee, KS, Sung, HH, Na, S, Choo, MS. Prevalence of urinary incontinence in Korean women:
results of a National Health Interview Survey. World J Urol 2008;26(2):179-185.
Ge, J, Yang, P, Zhang, Y, Li, X, Wang, Q, Lu, Y. Prevalence and risk factors of urinary
incontinence in Chinese women: A population-based study. Asia Pac J Public Health 2011.
[19]
[20]
Rohr, G, Stovring, H, Christensen, K, Gaist, D, Nybo, H, Kragstrup, J. Characteristics of middleaged and elderly women with urinary incontinence. Scand J Prim Health Care 2005;23(4):203208.
Dooley, Y, Kenton, K, Cao, G, Luke, A, Durazo-Arvizu, R, Kramer, H, et al. Urinary
incontinence prevalence: results from the National Health and Nutrition Examination Survey. J
Urol 2008;179(2):656-661.
Download